drugset / Trial / NCT01983722

Treatment Plan to Provide Expanded Access to Stiripentol for Patients With Dravet Syndrome

NCT01983722

Expanded access Approved for marketing Children's Hospital Medical Center, Cincinnati

Summary

Expanded access to Stiripentol for patients with Dravet Syndrome.

Timeline

Start
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Stiripentol Small molecule

Indications